Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

doi:10.1084/jem.180.3.1037

This Article

	Full Text (PDF, 1268K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Schodel, F.
	Articles by Milich, D.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Schodel, F.
	Articles by Milich, D.


Social Bookmarking

	What's this?

ARTICLES

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

F Schodel, R Wirtz, D Peterson, J Hughes, R Warren, J Sadoff and D Milich
Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100.

The hepatitis B virus (HBV) nucleocapsid antigen (HBcAg) was investigated as a carrier moiety for the immunodominant circumsporozoite (CS) protein repeat epitopes of Plasmodium falciparum and the rodent malaria agent P. berghei. For this purpose hybrid genes coding for [NANP]4 (C75CS2) or [DP4NPN]2 (C75CS1) as internal inserts in HBcAg (between amino acids 75 and 81) were constructed and expressed in recombinant Salmonella typhimurium. The resulting hybrid HBcAg-CS polypeptides purified from S. typhimurium were particulate and displayed CS and HBc antigenicity, however, the HBc antigenicity was reduced compared to native recombinant HBcAg. Immunization of several mouse strains with HBcAg-CS1 and HBcAg-CS2 particles resulted in high titer, P.berghei- or P.falciparum-specific anti-CS antibodies representing all murine immunoglobulin G isotypes. The possible influence of carrier-specific immunosuppression was examined, and preexisting immunity to HBcAg did not significantly affect the immunogenicity of the CS epitopes within HBcAg-CS1 particles. Similarly, the choice of adjuvant did not significantly alter the immunogenicity of HBcAg-CS hybrid particles. Immunization in complete or incomplete Freund's adjuvant or alum resulted in equivalent anti-HBc and anti-CS humoral responses. Examination of T cell recognition of HBcAg-CS particles revealed that HBcAg-specific T cells were universally primed and CS-specific T cells were primed if the insert contained a CS-specific T cell recognition site. This indicates that the internal site in HBcAg is permissive for the inclusion of heterologous pathogen-specific T as well as B cell epitopes. Most importantly, 90 and 100% of BALB/c mice immunized with HBcAg-CS1 particles were protected against a P. berghei challenge infection in two independent experiments. Therefore, hybrid HBcAg-CS particles may represent a useful approach for future malaria vaccine development.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Broos, K., Janssens, M. E., De Goeyse, I., Vanlandschoot, P., Leroux-Roels, G., Geysen, D., Guisez, Y. (2008). Comparison of Serum Humoral Responses Induced by Oral Immunization with the Hepatitis B Virus Core Antigen and the Cholera Toxin B Subunit. CVI 15: 852-858 [Abstract] [Full Text]
Hutchings, C. L., Birkett, A. J., Moore, A. C., Hill, A. V. S. (2007). Combination of Protein and Viral Vaccines Induces Potent Cellular and Humoral Immune Responses and Enhanced Protection from Murine Malaria Challenge. Infect. Immun. 75: 5819-5826 [Abstract] [Full Text]
Billaud, J.-N., Peterson, D., Barr, M., Chen, A., Sallberg, M., Garduno, F., Goldstein, P., McDowell, W., Hughes, J., Jones, J., Milich, D. (2005). Combinatorial Approach to Hepadnavirus-Like Particle Vaccine Design. J. Virol. 79: 13656-13666 [Abstract] [Full Text]
Oliveira, G. A., Wetzel, K., Calvo-Calle, J. M., Nussenzweig, R., Schmidt, A., Birkett, A., Dubovsky, F., Tierney, E., Gleiter, C. H., Boehmer, G., Luty, A. J. F., Ramharter, M., Thornton, G. B., Kremsner, P. G., Nardin, E. H. (2005). Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial. Infect. Immun. 73: 3587-3597 [Abstract] [Full Text]
Nardin, E. H., Oliveira, G. A., Calvo-Calle, J. M., Wetzel, K., Maier, C., Birkett, A. J., Sarpotdar, P., Corado, M. L., Thornton, G. B., Schmidt, A. (2004). Phase I Testing of a Malaria Vaccine Composed of Hepatitis B Virus Core Particles Expressing Plasmodium falciparum Circumsporozoite Epitopes. Infect. Immun. 72: 6519-6527 [Abstract] [Full Text]
Koser, M. L., McGettigan, J. P., Tan, G. S., Smith, M. E., Koprowski, H., Dietzschold, B., Schnell, M. J. (2004). Rabies virus nucleoprotein as a carrier for foreign antigens. Proc. Natl. Acad. Sci. USA 101: 9405-9410 [Abstract] [Full Text]
Birkett, A., Lyons, K., Schmidt, A., Boyd, D., Oliveira, G. A., Siddique, A., Nussenzweig, R., Calvo-Calle, J. M., Nardin, E. (2002). A Modified Hepatitis B Virus Core Particle Containing Multiple Epitopes of the Plasmodium falciparum Circumsporozoite Protein Provides a Highly Immunogenic Malaria Vaccine in Preclinical Analyses in Rodent and Primate Hosts. Infect. Immun. 70: 6860-6870 [Abstract] [Full Text]
Kratz, P. A., Bottcher, B., Nassal, M. (1999). Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc. Natl. Acad. Sci. USA 96: 1915-1920 [Abstract] [Full Text]
Fehr, T., Skrastina, D., Pumpens, P., Zinkernagel, R. M. (1998). T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc. Natl. Acad. Sci. USA 95: 9477-9481 [Abstract] [Full Text]